Position in MRNA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$273,746
+$59,371 QoQ
Shares Held
3,909
-7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#457
of 778 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AlTi Global, Inc. holds $6,262,398 across 9 Biotechnology names. MRNA ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
20,308 | $2,302,114 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,864 | $1,162,278 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,492 | $801,129 | |
| 4 | CELC |
Celcuity Inc.
|
5,287 | $553,125 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
95,493 | $367,648 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
716 | $355,658 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
3,909 | $273,746 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
921 | $225,433 |
All Filings in MRNA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $273,746 | 3,909 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $214,375 | 4,220 | Shares | Defined | 2026-05-07 | |
| 2024-06-30 | $331,430 | 2,791 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $293,146 | 2,751 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $273,586 | 2,751 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||